Corrigendum: Obesity and comorbidity: Could simultaneous targeting of esrage and srage be the panacea? (Front. Physiol. 10, 787, 10.3389/fphys.2019.00787)

Abstract

A Corrigendum on Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea? by Eleazu, C., Omar, N., Lim, O. Z., Yeoh, B. S., Nik Hussain, N. H., and Mohamed, M. (2019) Front. Physiol. 10:787. doi: 10.3389/fphys.2019.00787 In the original article, the reference for “Jaime et al. (2015)” was incorrectly written as “Jaime, U., Weijing, C., Mark, W., Elizabeth, T., Laurie, G., Renata, P., et al. (2015). Elevated serum advanced glycationendproducts in obese indicate risk for the metabolic syndrome: a link between Healthy and Unhealthy Obesity? J. Clin. Endocrinol. Metab. 100, 1957–1966. doi: 10.1210/jc.2014-3925.” It should be “Uribarri, J., Cai, W., Woodward, M., Tripp, E., Goldberg, L., Pyzik, R., et al. (2015). Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity? J. Clin. Endocrinol. Metab. 100, 1957–1966. doi: 10.1210/jc.2014-3925.” The reference has been updated and the citation has been corrected to Uribarri et al. (2015) in the section Targeting of esRage and sRage Signaling as a Beneficial Therapeutic Approach for Obesity and Its Comorbidity, paragraph 18 and should read:.